Application 079141
- Type
- ANDA
- Sponsor
- TEVA PHARMS USA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOLTERODINE TARTRATE | TOLTERODINE TARTRATE | CAPSULE, EXTENDED RELEASE;ORAL | 2MG | No | No |
| 002 | TOLTERODINE TARTRATE | TOLTERODINE TARTRATE | CAPSULE, EXTENDED RELEASE;ORAL | 4MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079141-001 | TOLTERODINE TARTRATE | TOLTERODINE TARTRATE | 2MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2016-11-22 | |
| A079141-002 | TOLTERODINE TARTRATE | TOLTERODINE TARTRATE | 4MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2016-11-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A079141-001 | AB |
| A079141-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079141-001 | TOLTERODINE TARTRATE | 2MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2016-11-22 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079141-002 | TOLTERODINE TARTRATE | 4MG | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2016-11-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079141-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079141-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tolterodine Tartrate | TOLTERODINE TARTRATE | A-S Medication Solutions | fd6c8b3d-a52a-4418-aa9c-0297db6c0807 | 2026-01-09 | Warnings, Adverse reactions | 079141 ANDA079141 50090-3475 |
| Tolterodine Tartrate | TOLTERODINE TARTRATE | Teva Pharmaceuticals USA, Inc. | 973f98b5-4e8a-42d9-ac69-d4333d21c362 | 2024-09-25 | Warnings, Adverse reactions | 079141 ANDA079141 0093-7164 0093-7163 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0093-7163 | Tolterodine Tartrate | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7163 | Tolterodine Tartrate | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7163 | Tolterodine Tartrate | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7163 | Tolterodine Tartrate | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7163 | Tolterodine Tartrate | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7163 | Tolterodine Tartrate | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7164 | Tolterodine Tartrate | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7164 | Tolterodine Tartrate | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7164 | Tolterodine Tartrate | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7164 | Tolterodine Tartrate | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7164 | Tolterodine Tartrate | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-7164 | Tolterodine Tartrate | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 50090-3475 | Tolterodine Tartrate | Tolterodine Tartrate | A-S Medication Solutions | ANDA | Current |
| 50090-3475 | Tolterodine Tartrate | Tolterodine Tartrate | A-S Medication Solutions | ANDA | Current |
| 50090-3475 | Tolterodine Tartrate | Tolterodine Tartrate | A-S Medication Solutions | ANDA | Current |
| 50090-5995 | Tolterodine Tartrate | Tolterodine Tartrate | A-S Medication Solutions | ANDA | Current |